News
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...
The U.S. Food and Drug Administration is changing the way it approves COVID-19 vaccines for Americans — a move that will ...
FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among ...
Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
Sustained applause echoed in a Geneva hall hosting the WHO's annual assembly as the measure — debated and devised over three ...
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
The requirement for placebo-controlled trials isn’t expected to affect the rollout this fall for older adults and other groups at high risk for severe illness.
WHO members on Tuesday adopted a treaty that outlines how to prepare for and respond to pandemics. One country missing: the U ...
The FDA announced it will limit full approval of future COVID-19 booster vaccines to individuals older than 65 and those at high risk for severe disease, marking a shift from the agency’s previous one ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results